Literature DB >> 30257586

Effect of curcumin nanoparticles on the cisplatin-induced neurotoxicity in rat.

Yasser A Khadrawy1, Mayada M El-Gizawy1, Safwa M Sorour2, Hussein G Sawie1, Eman N Hosny1.   

Abstract

The present study is conducted to evaluate the neuroprotective effect of curcumin nanoparticles (CUR NP) against the neurotoxicity induced by cisplatin (CP) in rat. Rats were divided into control group that received saline solution, CP-treated rats that received a single i.p. injection of CP (12 mg/kg body wt), and CP-treated rats that received a single i.p injection of CP (12 mg/kg body wt) followed by a daily oral administration of CUR NP (50 mg/kg body wt) for 14 days. At the end of the experiment, the motor activity of rats was evaluated by open field test. The neurochemical and histopathological changes were investigated in the cerebral cortex. A significant decrease in motor activity was observed in CP-treated rats. This was associated with a significant increase in the cortical levels of lipid peroxidation, nitric oxide, tumor necrosis factor-α, caspase-3, and acetylcholinesterase activity. However, CP induced a significant decrease in reduced glutathione levels and Na+, K+-ATPase activity. In rats treated with CP and CUR NP, no significant changes were recorded in the parameters of the open field test as compared to control. In addition, treatment with CUR NP prevented all the neurochemical changes induced by CP except the increased value of nitric oxide. CUR NP also reduced the histopathological changes induced by CP. It is clear from the present data that CUR NP could ameliorate the neurotoxic effect induced by cisplatin.

Entities:  

Keywords:  Cisplatin; TNF-α; caspase-3; curcumin nanoparticles; neurotoxicity; oxidative stress

Mesh:

Substances:

Year:  2018        PMID: 30257586     DOI: 10.1080/01480545.2018.1504058

Source DB:  PubMed          Journal:  Drug Chem Toxicol        ISSN: 0148-0545            Impact factor:   3.356


  8 in total

Review 1.  Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity.

Authors:  Ivan K Domingo; Asna Latif; Amit P Bhavsar
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

2.  Reversal of cisplatin triggered neurotoxicity by Acacia hydaspica ethyl acetate fraction via regulating brain acetylcholinesterase activity, DNA damage, and pro-inflammatory cytokines in the rodent model.

Authors:  Tayyaba Afsar; Suhail Razak; Ali Almajwal
Journal:  BMC Complement Med Ther       Date:  2022-07-05

3.  The Effect of Curcumin Nanoparticles on Cisplatin-Induced Cardiotoxicity in Male Wistar Albino Rats.

Authors:  Yasser A Khadrawy; Eman N Hosny; Mayada M El-Gizawy; Hussein G Sawie; Heba S Aboul Ezz
Journal:  Cardiovasc Toxicol       Date:  2021-02-06       Impact factor: 3.231

Review 4.  Platinum-Induced Peripheral Neuropathy (PIPN): ROS-Related Mechanism, Therapeutic Agents, and Nanosystems.

Authors:  Xi Hu; Zhijie Jiang; Longyu Teng; Hongyu Yang; Dongsheng Hong; Dongsheng Zheng; Qingwei Zhao
Journal:  Front Mol Biosci       Date:  2021-11-24

5.  Sustainable Release of Propranolol Hydrochloride Laden with Biconjugated-Ufasomes Chitosan Hydrogel Attenuates Cisplatin-Induced Sciatic Nerve Damage in In Vitro/In Vivo Evaluation.

Authors:  Yasmin M Ahmed; Raha Orfali; Doaa S Hamad; Mostafa E Rateb; Hanan O Farouk
Journal:  Pharmaceutics       Date:  2022-07-23       Impact factor: 6.525

6.  Neuroprotective Potential of Intranasally Delivered Sulforaphane-Loaded Iron Oxide Nanoparticles Against Cisplatin-Induced Neurotoxicity.

Authors:  Ghadha Ibrahim Fouad; Sara A M El-Sayed; Mostafa Mabrouk; Kawkab A Ahmed; Hanan H Beherei
Journal:  Neurotox Res       Date:  2022-08-15       Impact factor: 3.978

Review 7.  Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Giulia Fumagalli; Laura Monza; Guido Cavaletti; Roberta Rigolio; Cristina Meregalli
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561

8.  Neuroprotective Potential of Bone Marrow-Derived Mesenchymal Stem Cells Following Chemotherapy.

Authors:  Iman O Sherif; Nora H Al-Shaalan; Dina Sabry
Journal:  Biomedicines       Date:  2021-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.